StockWatch
·
Medical/Nursing Services
Corporate GovernanceMay 18, 2026, 02:26 PM

Chemed Stockholders Reject Executive Comp; Declares $0.60 Dividend

AI Summary

Chemed Corporation stockholders elected nine directors and ratified PricewaterhouseCoopers LLP as independent accountants for 2026 at the annual meeting. Notably, a non-binding proposal on executive compensation was not approved. Following the meeting, Chemed's Board of Directors declared a quarterly cash dividend of $0.60 per share, marking the company's 220th consecutive quarterly dividend.

Key Highlights

  • Stockholders elected a slate of nine directors at the 2026 annual meeting.
  • PricewaterhouseCoopers LLP ratified as independent accountants for 2026.
  • Non-binding executive compensation proposal was not approved by stockholders.
  • Board declared a quarterly cash dividend of $0.60 per share.
  • Dividend payable June 16, 2026, to stockholders of record May 28, 2026.
  • This marks the 220th consecutive quarterly dividend paid by Chemed.